Insider · CIK 0001307935

Watkins Thomas

Reports to the SEC for 3 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001307935

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−110K sh	$116.50	−$12.9M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−56K sh	$116.50	−$6.52M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$116.50	−$1.17M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,548 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.8K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-09-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$12.29	+$492K	69,124
2023-09-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$15.96	+$319K	89,124
2023-09-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+21.3K sh	$13.87	+$296K	110,447
2023-09-29	Horizon Therapeutics Public Ltd CoStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2023-09-29	Horizon Therapeutics Public Ltd CoStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2023-09-29	Horizon Therapeutics Public Ltd CoStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.3K sh	—	—	10,838
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	29,124
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2022-06-02	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$4.15	+$62.3K	69,505
2022-06-02	VNDAVanda Pharmaceuticals Inc.S Sale	Director	SSale	−6,441 sh	$9.90	−$63.8K	63,064
2022-06-02	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	75,164
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-06-10	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	54,505
2021-06-10	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	70,941
2021-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2021-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,223 sh	—	—	4,223
2021-02-16	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$7.11	+$107K	55,323
2021-02-16	VNDAVanda Pharmaceuticals Inc.S Sale	Director	SSale	−5,818 sh	$18.54	−$108K	49,505
2021-02-16	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2020-06-11	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	40,323
2020-06-11	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-05-29	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$7.38	+$111K	45,000
2020-05-29	VNDAVanda Pharmaceuticals Inc.S Sale	Director	SSale	−9,677 sh	$11.50	−$111K	35,323
2020-05-29	VNDAVanda Pharmaceuticals Inc. · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2020-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.4K sh	—	—	59,843
2020-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.4K sh	—	—	0
2020-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+11.1K sh	—	—	11,098
2019-06-13	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	30,000
2019-06-13	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+15.3K sh	—	—	48,585
2019-05-03	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,132 sh	$26.54	−$110K	44,453
2019-05-03	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.3K sh	—	—	0
2019-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+15.4K sh	—	—	15,390
2018-06-13	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	25,000
2018-06-13	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-03	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$4.98	+$74.7K	20,000
2018-05-03	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	—	—	0
2018-05-03	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+14.1K sh	—	—	33,265

Recent filings

Accepted (ET)
Oct 64
Watkins Thomas0001209191-23-052376
SEC(opens sec.gov)
Oct 24
Watkins Thomas0001209191-23-051234
SEC(opens sec.gov)
Jul 284
Watkins Thomas0001209191-23-043698
SEC(opens sec.gov)
May 24
Watkins Thomas0001209191-23-026757
SEC(opens sec.gov)
Jun 34
Watkins Thomas0001209191-22-034062
SEC(opens sec.gov)

Companies

Address

14200 SHADY GROVE ROAD

ROCKVILLE, MD, 20850